Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs3785277 | chr16:89839142 | G/C | 0.000168 | 177 | 25.87 | 20.2 | 36.37 | KM Plot |
PCPG | rs3785279 | chr16:89824562 | G/C | 0.000179 | 176 | 25.87 | 20.17 | 36.37 | KM Plot |
PCPG | rs3785281 | chr16:89824263 | G/C | 0.000179 | 176 | 25.87 | 20.17 | 36.37 | KM Plot |
PCPG | rs3792269 | chr2:241531479 | A/G | 3.44E-5 | 178 | 25.92 | 20.2 | 10.3 | KM Plot |
PCPG | rs3792273 | chr2:241533030 | C/T | 0.000344 | 178 | 18.78 | 20.2 | 25.87 | KM Plot |
PCPG | rs3792275 | chr2:241536692 | G/A | 3.44E-5 | 178 | 25.92 | 20.2 | 10.3 | KM Plot |
PCPG | rs3793218 | chr7:158852659 | T/C | 0.000211 | 173 | 25.4 | 23.35 | 41.87 | KM Plot |
PCPG | rs3793778 | chr10:1079372 | A/G | 1.28E-5 | 175 | 24.62 | 29.57 | 13.38 | KM Plot |
PCPG | rs3803676 | chr16:89596106 | C/T | 0.000306 | 178 | 27.6 | 25.4 | 19.53 | KM Plot |
PCPG | rs3803679 | chr16:89590667 | T/C | 8.51E-5 | 173 | 27.6 | 25.67 | 18.2 | KM Plot |
PCPG | rs3803680 | chr16:89590243 | G/A | 0.000192 | 177 | 26.78 | 25.4 | 19.53 | KM Plot |
PCPG | rs3806202 | chr1:40505872 | C/T | 2.96E-6 | 173 | 25 | 22.3 | 37.18 | KM Plot |
PCPG | rs3809641 | chr16:89574166 | C/G | 0.000256 | 175 | 26.78 | 25.28 | 19.2 | KM Plot |
PCPG | rs3816155 | chr2:136552526 | A/C | 3.02E-5 | 175 | 9.72 | 23.77 | 25.67 | KM Plot |
PCPG | rs3817040 | chr3:122254769 | G/A | 1.01E-10 | 173 | 25.4 | 25.92 | 5.8 | KM Plot |